Back to Results
First PageMeta Content
Interstitial cystitis / Chronic prostatitis/chronic pelvic pain syndrome / Cystitis / Overactive bladder / Urinary bladder disease / Urination / Urinary tract infection / Urinary urgency / Bladder cancer / Medicine / Health / Urology


TARIS® Secures $12.5 Million in Additional Financing; Initiates Phase 2 Trial of Lead Product Candidate Lexington, MA – April 2nd, 2013 – TARIS Biomedical®, a specialty pharmaceutical company developing innovative,
Add to Reading List

Document Date: 2013-04-02 09:23:50


Open Document

File Size: 313,77 KB

Share Result on Facebook
UPDATE